Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer. Randomized Phase III Study.

Trial Profile

Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer. Randomized Phase III Study.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Mar 2018

At a glance

  • Drugs Cytarabine (Primary)
  • Indications Brain metastases; Carcinomatous meningitis
  • Focus Therapeutic Use
  • Acronyms DEPOSEIN
  • Most Recent Events

    • 22 Mar 2018 Planned End Date changed from 1 Jul 2017 to 1 Jan 2019.
    • 22 Mar 2018 Planned primary completion date changed from 1 Jan 2017 to 1 Aug 2018.
    • 22 Mar 2018 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top